B
Bicara Therapeutics Inc
NASDAQ:BCAX
Bicara Therapeutics Inc
NASDAQ:BCAX
Price:
14.99
USD
-2.41%
Market Closed
Market Cap:
$821.2m
Income Statement
Earnings Waterfall
Bicara Therapeutics Inc
Bicara Therapeutics Inc
Income Statement
Bicara Therapeutics Inc
Bicara Therapeutics Inc
Currency: USD
| Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(96)
|
(82)
|
(124)
|
(121)
|
(141)
|
|
| Selling, General & Administrative |
(21)
|
(19)
|
(26)
|
(26)
|
(29)
|
|
| Research & Development |
(74)
|
(64)
|
(98)
|
(95)
|
(112)
|
|
| Operating Income |
(96)
N/A
|
(82)
+14%
|
(124)
-51%
|
(121)
+3%
|
(141)
-17%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
10
|
15
|
20
|
19
|
20
|
|
| Total Other Income |
(13)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(99)
N/A
|
(68)
+32%
|
(105)
-54%
|
(102)
+2%
|
(121)
-18%
|
|
| Net Income | ||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(99)
|
(68)
|
(105)
|
(103)
|
(122)
|
|
| Net Income (Common) |
(99)
N/A
|
(68)
+31%
|
(105)
-54%
|
(103)
+2%
|
(122)
-18%
|
|
| EPS (Diluted) |
-1.81
N/A
|
-4.05
-124%
|
-1.92
+53%
|
-1.88
+2%
|
-2.22
-18%
|
|
Switch to:
Switch to:
See Also
Discover More
